Pancreatic Cancer

Nic Dakin Excerpts

Tuesday 4th March 2014 Commons Chamber

[Nic Dakin (Scunthorpe) (Lab)]

I congratulate the hon. Member for Lancaster and Fleetwood (Eric Ollerenshaw) on securing this debate and setting the scene so well. Pancreatic cancer needs all our efforts if we are to make a difference. I pay tribute to pancreatic cancer patients up and down the land, including my good friend Sir John Mason, who is battling the disease, and all the families and friends of those with pancreatic cancer, as well as those working with and supporting them.

As the hon. Gentleman said, survival rates from the disease have not changed for 40 years. Abraxane gives the opportunity not only for two more months, but to bring about change and transform how the disease is dealt with in future. In the United States, there is already innovation in how the disease is being tackled. I hope that the people having to make these difficult decisions listen to this debate and take it into account when making the decisions in a proper and objective way. It is important that our voices echo those of people who are contacting us about the condition, including my constituent Maggie Watts who has assembled a petition of 45,117 names of people who are shouting for something to be done about this disease.

That is all I want to say; I wanted to add my support to that of the hon. Member the Member for Lancaster and Fleetwood with whom I have worked on the all-party parliamentary group on pancreatic cancer.